Immune checkpoint inhibitors break whose heart? Perspectives from cardio-immuno-oncology.

Authors:
He Y; Yu H; Dai S; He M; Ma L and 3 more

Journal:
Genes Dis

Publication Year: 2023

DOI:
10.1016/j.gendis.2023.01.024

PMCID:
PMC10491874

PMID:
37692505

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Genes Dis

Abbreviation: Genes Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Genetics & Heredity

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
LKB1 depletion-mediated epithelial-mesenchymal transition induces fibroblast activation in lung fib…
Xu Z; Davies ER; Yao L and 11 more (2024) - Transparency Score: 4/6
Advances in oral mesenchymal stem cell-derived extracellular vesicles in health and disease.
Luo H; Birjandi AA; Ren F and 4 more (2023) - Transparency Score: 3/6
A <i>BBS4</i> mutation causes autosomal dominant polycystic liver disease.
Cui Y; Xu W; Liu J and 6 more (2023) - Transparency Score: 3/6
An analysis of the transcriptional landscape in hypoxia-treated primary nucleus pulposus cells.
Peng Z; Wang Z; Guo S and 7 more (2023) - Transparency Score: 3/6
A novel preimplantation genetic testing strategy for a subtelomeric genetic disorder: A case study.
Chen S; Wang L; Chen L and 10 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interests There is neither financial support nor other benefits from commercial sources to be reported for the work presented in the manuscript, nor any other financial interests that any of the authors may have, which could create a potential conflict of interest or the appearance of a conflict of interest concerning the work."

Evidence found in paper:

"Funding This work was supported by a fund from Deyang Science and Technology Foundation (Sichuan, China) (No. 2019SZ120)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025